Dow Gains 100 Points; US Inflation Rate Rises To 3.2% In February

Benzinga03-12

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 100 points on Tuesday.

Following the market opening Tuesday, the Dow traded up 0.27% to 38,873.55 while the NASDAQ rose 0.69% to 16,129.18. The S&P 500 also rose, gaining, 0.52% to 5,144.57.

Check This Out: Insiders Buying Keurig Dr Pepper And 3 Other Stocks

Leading and Lagging Sectors

Information technology shares jumped by 0.7% on Tuesday.

In trading on Tuesday, utilities shares fell by 0.3%.

Top Headline

The U.S. consumer price index exceeded expectations in February.

In February 2024, the inflation rate climbed to 3.2% compared to the previous year, surpassing both the previous and expected rate of 3.1%. On a monthly basis, the core CPI increased by 0.4%, in line with January’s figure and exceeding the predicted 0.3% rise.

Equities Trading UP

ClearOne, Inc. (NASDAQ:CLRO) shares shot up 130% to $2.089 after the company announced a special-one time cash dividend.

Shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) got a boost, surging 81% to $2.50 after the company announced topline results from the second cohort of patients in its Phase 1b MAD study of RGLS8429 for the treatment of ADPKD. The company announced an oversubscribed $100 million private placement of equity.

Ranpak Holdings Corp. (NASDAQ:PACK) shares were also up, gaining 46% to $6.38 after the company reported better-than-expected fourth-quarter revenue results and issued FY24 guidance. Also, Baird maintained an Outperform rating on the stock and raised its price target from $5 to $7.

Equities Trading DOWN

BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) shares dropped 72% to $0.0285 after the company announced pricing of $7.0 million underwritten public offering.

Shares of Blade Air Mobility, Inc.. (NASDAQ:BLDE) were down 29% to $2.8150 after the company reported worse-than-expected fourth-quarter revenue results and issued FY24 revenue guidance below estimates.

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) was down, falling 23% to $0.5150. NRx Pharmaceuticals initiated a strategy to combat short sellers in the company's stock.

Also Check This Out: Top 5 Energy Stocks You May Want To Dump In March

Commodities

In commodity news, oil traded up 0.1% to $77.99 while gold traded down 1.1% at $2,165.70.

Silver traded down 1.4% to $24.375 on Tuesday while copper fell 0.4% to $3.9135.

Euro zone

European shares were higher today. The eurozone’s STOXX 600 rose 0.4%, London’s FTSE 100 rose 1% while Spain’s IBEX 35 Index rose 0.3% The German DAX rose 0.3% French CAC 40 rose 0.1% while Italy’s FTSE MIB Index gained 0.5%.

German consumer price inflation came in at 2.5% year-over-year in February. The UK’s unemployment rate rose to 3.9%, while regular pay, excluding bonus payment, increased 6.1% year-over-year to GBP 627/week in the three months to January.

Asia Pacific Markets

Asian markets closed mixed on Tuesday, with Japan’s Nikkei 225 falling 0.06%, Hong Kong’s Hang Seng Index gaining 3.05%, China’s Shanghai Composite Index falling 0.41% and India’s S&P BSE Sensex gaining 0.23%.

Total passenger vehicle sales in India climbed 9.5% year-over-year to 319,519 in February. Producer prices in Japan increased by 0.6% year-over-year in February, while business survey index of large manufacturing firms dipped to -6.7% in the first quarter compared to 5.7% in the prior quarter.

Economics

The NFIB Small Business Optimism Index fell to 89.4 in February from 89.9 in January.

In February 2024, the inflation rate climbed to 3.2% compared to the previous year, surpassing both the previous and expected rate of 3.1%. On a monthly basis, the core CPI increased by 0.4%, in line with January’s figure and exceeding the predicted 0.3% rise.

Now Read This: Oracle To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment